Cryosite (ASX:CTE) Common Stock : A$5.98 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Cryosite Common Stock?

Cryosite's quarterly common stock stayed the same from Dec. 2022 (A$5.98 Mil) to Jun. 2023 (A$5.98 Mil) and stayed the same from Jun. 2023 (A$5.98 Mil) to Dec. 2023 (A$5.98 Mil).

Cryosite's annual common stock increased from Jun. 2021 (A$5.86 Mil) to Jun. 2022 (A$5.98 Mil) but then stayed the same from Jun. 2022 (A$5.98 Mil) to Jun. 2023 (A$5.98 Mil).

Cryosite Common Stock Historical Data

The historical data trend for Cryosite's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryosite Common Stock Chart

Cryosite Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Common Stock

Get a 7-Day Free Trial

5.86

5.98

Cryosite Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Common Stock	Get a 7-Day Free Trial															5.98	5.98	5.98	5.98	5.98

Cryosite Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Cryosite (ASX:CTE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cryosite Ltd (ASX:CTE) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

13a Ferndell Street, South Granville, Sydney, NSW, AUS, 2142

Website

https://www.cryosite.com

Cryosite Ltd is engaged in the provision of supply chain logistics, management of pharmaceutical products used in clinical trials. The company's operating segment includes Cord Blood and Tissue Storage and Clinical Trials and Biological Services Logistics. It generates maximum revenue from the Clinical Trials and Biological Services Logistics segment. Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services.

Cryosite (ASX:CTE) Headlines

No Headlines